Authorized purpose: Merge PACS is a multi-modality image-management and diagnostic-viewing system for processing, displaying, communicating, reporting, printing, storing, and retrieving supported DICOM and related clinical images for radiologists, surgeons, referring physicians, and other authorized users.
Radiological images; modality varies or is not specified in FDA list · Multi-region
Key limitation
Keep in mind: Not every viewer, advanced-visualization, AI, cloud, or integration feature in current family materials belongs to the cleared version; verify licensed components and diagnostic-display requirements.
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
What does this software do?Authorized purpose: Merge PACS is a multi-modality image-management and diagnostic-viewing system for processing, displaying, communicating, reporting, printing, storing, and retrieving supported DICOM and related clinical images for radiologists, surgeons, referring physicians, and other authorized users.
Which images or clinical context are in scope?Modality: Radiological images; modality varies or is not specified in FDA list Anatomy or clinical context: Multi-region Input: Supported DICOM and non-DICOM clinical images and related patient or workflow data.
Who uses it?Intended users: Radiologists, cardiologists, technologists, sonographers, surgeons, and other trained clinical users.
What does the software produce?Output: Displayed images, measurements, segmentations, reformats, reports, and routed clinical objects.
What is its most important limitation?Key limitation: Not every viewer, advanced-visualization, AI, cloud, or integration feature in current family materials belongs to the cleared version; verify licensed components and diagnostic-display requirements.
Clinical takeaway. Clinical role: Merge PACS is a multi-modality image-management and diagnostic-viewing system for processing, displaying, communicating, reporting, printing, storing, and retrieving supported DICOM and related clinical images for radiologists, surgeons, referring physicians, and other authorized users.
Evidence takeaway. Evidence from the reviewed source record: The K192455 FDA decision summary describes Merge PACS support for CT, MR, PET, ultrasound, mammography, breast tomosynthesis, CR, DR/DX, nuclear medicine, XA, RF, and secondary-capture image workflows, with professional diagnostic review and reporting. Because the cleared scope spans many modalities, the directory preserves a variable or unspecified modality rather than forcing one modality label; no AI classifier sensitivity or specificity is established.
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
Merge PACS is a multi-modality image-management and diagnostic-viewing system for processing, displaying, communicating, reporting, printing, storing, and retrieving supported DICOM and related clinical images for radiologists, surgeons, referring physicians, and other authorized users.
Not every viewer, advanced-visualization, AI, cloud, or integration feature in current family materials belongs to the cleared version; verify licensed components and diagnostic-display requirements.
The K192455 FDA decision summary describes Merge PACS support for CT, MR, PET, ultrasound, mammography, breast tomosynthesis, CR, DR/DX, nuclear medicine, XA, RF, and secondary-capture image workflows, with professional diagnostic review and reporting. Because the cleared scope spans many modalities, the directory preserves a variable or unspecified modality rather than forcing one modality label; no AI classifier sensitivity or specificity is established.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
The K192455 FDA decision summary describes Merge PACS support for CT, MR, PET, ultrasound, mammography, breast tomosynthesis, CR, DR/DX, nuclear medicine, XA, RF, and secondary-capture image workflows, with professional diagnostic review and reporting. Because the cleared scope spans many modalities, the directory preserves a variable or unspecified modality rather than forcing one modality label; no AI classifier sensitivity or specificity is established.
Sensitivity is not the primary endpoint for this system, reconstruction, segmentation, guidance, or quantitative function. Use the task-specific evidence below.
Reported specificity
Not applicable
Not applicable
Not applicable
Checked 2026-09-03
Specificity is not the primary endpoint for this system, reconstruction, segmentation, guidance, or quantitative function. Use the task-specific evidence below.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
K192455 FDA performance package for Merge PACS
DesignManufacturer software, DICOM, image-display, reporting, storage, communication, and usability verification and validation submitted in K192455
PopulationMulti-modality DICOM image-management, diagnostic-reading, reporting, communication, storage, and retrieval workflows across the supported clinical departments
Scopeexact submission
Tested versionMerge PACS (K192455)
IndependenceSponsor or vendor study
K192455
Manufacturer evidence submitted for FDA clearance or approval; local clinical, technical, and workflow acceptance remains necessary.
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
4 exact-submission FDA recall records in the 2026-09-02 openFDA snapshot identify K192455. Affected model, version, unit, correction, and current manufacturer instructions still require local confirmation. FDA recall Z-3004-2026 is Open, Classified for Merge PACS and Merge OrthoPACS, medical imaging diagnostic workstation. FDA reason: Software issue may cause measurements to be displayed inaccurately. FDA action: Merge Healthcare issued an Urgent Field Safety Notice to its consignees on 7/22/2026 via email with a follow-up telephone call. The notice explained the issue and how to identify it, risk to patient, and requested the following: "Immediate actions to reduce risk to patients Merge Healthcare recommends that customers contact Merge Healthcare Support to identify any affected ultrasound studies and the necessary next steps to be taken. Until the software update is installed, ultrasound measurements performed using the Merge PACS & OrthoPACS Viewer should be confirmed against the measurements acquired at the ultrasound modality." The required actions are as follows: "Merge Healthcare Support will contact all customers to: i) Confirm that you have read and understood this Urgent Field Safety Notice. ii) Assist you in identifying and reviewing any ultrasound studies with measurements that may have been affected. iii) Schedule the installation of the software update that eliminates the root cause of this issue. Please forward this notice to any individuals within the organization that may need to be aware of this notification. Customers should alert any other affiliated parties that may be affected by this Urgent Field Safety Notice. For more information, please contact Merge Healthcare Support at 1-877-741-5369 (available 24 hours a day, 7 days a week) or visit our website: https://www.merative.com/support/merge. FDA recall Z-2874-2026 is Open, Classified for Merge PACS, medical imaging diagnostic workstation. FDA reason: Merge Healthcare has identified a potential issue that may cause thumbnails from a previously opened patient study to be displayed in the Thumbnail Bar while a different patient study is open. FDA action: Merge Healthcare issued an Urgent Field Safety Notice (Revision 2) to its consignees on 6/30/2026 via email. The notice explained the issue and when it may occur, risk to patient, and requested an immediate workaround, a configuration change, be performed to disable automatic refresh of the Thumbnail Bar until a software update is available. The notice also directions the consignee to forward the notice to any individuals within their organization that may need to be aware of this notification. Customers should alert any other affiliated parties that may be affected by this Urgent Field Safety Notice. The notice was followed by telephone calls beginning on 7/6/2026 to ensure the notice was received. For more information, please contact Merge Healthcare Support at 1-877-741-5369 (available 24 hours a day, 7 days a week) or visit our website: https://www.merative.com/support/merge. FDA recall Z-2875-2026 is Open, Classified for Merge OrthoPACS, medical imaging diagnostic workstation. FDA reason: Merge Healthcare has identified a potential issue that may cause thumbnails from a previously opened patient study to be displayed in the Thumbnail Bar while a different patient study is open. FDA action: Merge Healthcare issued an Urgent Field Safety Notice (Revision 2) to its consignees on 6/30/2026 via email. The notice explained the issue and when it may occur, risk to patient, and requested an immediate workaround, a configuration change, be performed to disable automatic refresh of the Thumbnail Bar until a software update is available. The notice also directions the consignee to forward the notice to any individuals within their organization that may need to be aware of this notification. Customers should alert any other affiliated parties that may be affected by this Urgent Field Safety Notice. The notice was followed by telephone calls beginning on 7/6/2026 to ensure the notice was received. For more information, please contact Merge Healthcare Support at 1-877-741-5369 (available 24 hours a day, 7 days a week) or visit our website: https://www.merative.com/support/merge. FDA recall Z-2944-2020 is Terminated for Merge PACS. FDA reason: Measurements done on the Merge PACS generated MPR s may have incorrect measurements. FDA action: The firm, IBM Watson Health, sent an "Urgent Field Safety Notice" dated 05 August 2020 to its customers. The letter described the product, problem, and actions to be taken. The customers were instructed to do the following: Avoid incorrect pixel measurements by using the following workflow: Step 1: Modality acquires a series and generates reformat and sends to Merge PACS Step 2: Radiologist performs measurement on these series from the modality. Avoid black dots that may lead to additional imaging by taking any of the following actions: - Verifying study images either at modality or in another viewer. - Increasing the window level will window out the lowest pixel value (the black dots). - Viewing additional images/series within the study. Viewing of prior series/studies. - Verifying patients history, diagnosis or other clinical data. IBM Watson Health/Merge Healthcare will provide a software correction to address these issues. A representative will be in contact with you to schedule the software update. Please ensure all potential users of Merge PACS v8.1, 8.1.1 and 8.1.2 have received this notice. Please provide this notice to other organizations impacted by this action. If you have any questions regarding this notice, please contact Customer Support at WHISupport@us.ibm.com or 877-741-5369.
FDA source
Exact FDA submission
Checked 2026-09-04
Each published event was manually matched to the exact FDA submission and affected product or version; a recall does not establish an AI-algorithm defect or current site exposure unless the event states that scope.
Exact native submission match in the checked openFDA snapshot. Published as a product, system, labeling, or postmarket issue; the FDA record does not identify an AI-algorithm defect unless it says so. Confirm affected model, version, units, corrective action, and completion status locally.
Exact native submission match in the checked openFDA snapshot. Published as a product, system, labeling, or postmarket issue; the FDA record does not identify an AI-algorithm defect unless it says so. Confirm affected model, version, units, corrective action, and completion status locally.
Exact native submission match in the checked openFDA snapshot. Published as a product, system, labeling, or postmarket issue; the FDA record does not identify an AI-algorithm defect unless it says so. Confirm affected model, version, units, corrective action, and completion status locally.
Exact native submission match in the checked openFDA snapshot. Published as a product, system, labeling, or postmarket issue; the FDA record does not identify an AI-algorithm defect unless it says so. Confirm affected model, version, units, corrective action, and completion status locally.
No separate named-product Medicare payment was identified in the reviewed CMS coverage material. Evaluate the product within the applicable imaging, procedural, or surgical service line and verify payer, site-of-service, and coding assumptions independently.
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: Supported DICOM and non-DICOM clinical images and related patient or workflow data.
Scope: Exact FDA submission.
Confirm scanner/model, protocol, series completeness and both software builds.
Source context, not route validation: Validate modality and archive connectivity, DICOM objects, patient reconciliation, worklists, priors, reporting, identity, routing, display calibration, AI-result ingestion, and downtime recovery.
Scope: Product family. Current vendor materials are product-family evidence for K192455; confirm the exact cleared version, enabled options, deployment, and local compatibility.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Source context, not route validation: Web and server software deployed on supported on-premises or contracted hosted infrastructure for the exact release.
Scope: Product family. Current vendor materials are product-family evidence for K192455; confirm the exact cleared version, enabled options, deployment, and local compatibility.
Confirm processing location, queue ownership, exclusions and exact AI build.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
Web and server software deployed on supported on-premises or contracted hosted infrastructure for the exact release.
Product family
Checked 2026-09-03
Current vendor materials are product-family evidence for K192455; confirm the exact cleared version, enabled options, deployment, and local compatibility.
Current vendor materials are product-family evidence for K192455; confirm the exact cleared version, enabled options, deployment, and local compatibility.
Only radiologists, cardiologists, technologists, sonographers, surgeons, and other trained clinical users should operate or interpret the product. Local onboarding should cover the exact release, supported population, limitations, failure examples, escalation, downtime, and competency documentation.
Monitor by exact hardware, software, model, and algorithm version; patient population; anatomy; protocol; operator; input quality; output edits or overrides; failed studies; repeat acquisition or rework; downstream impact; downtime; incidents; recalls; and updates. Track these product-specific limits: Not every viewer, advanced-visualization, AI, cloud, or integration feature in current family materials belongs to the cleared version; verify licensed components and diagnostic-display requirements.
Product family
Checked 2026-09-03
Current vendor materials are product-family evidence for K192455; confirm the exact cleared version, enabled options, deployment, and local compatibility.
Test representative identifiers, orientation, geometry, measurements, units, routing, failure handling, and round trips locally. Vendor statements are current product-family context; confirm the exact cleared release and installed options.
Use a signed local test set for the supported population and workflow. Include common and difficult cases, exclusions, acquisition variation, failed or low-quality inputs, reviewer overrides, and downstream effects. Not every viewer, advanced-visualization, AI, cloud, or integration feature in current family materials belongs to the cleared version; verify licensed components and diagnostic-display requirements.
exact submission · checked 2026-09-03
Define stop-use, escalation, rollback, and revalidation triggers before production use.
Model capital and recurring cost against net staff time after review, throughput, repeat imaging or rework, room time, consumables, infrastructure, training, service, downtime, upgrade, and replacement costs.
product family · checked 2026-09-03
No exact-product price was found in the reviewed public material; vendor productivity claims are scenario inputs, not guaranteed local savings.
Monitor by exact hardware, software, model, and algorithm version; patient population; anatomy; protocol; operator; input quality; output edits or overrides; failed studies; repeat acquisition or rework; downstream impact; downtime; incidents; recalls; and updates. Track these product-specific limits: Not every viewer, advanced-visualization, AI, cloud, or integration feature in current family materials belongs to the cleared version; verify licensed components and diagnostic-display requirements.
product family · checked 2026-09-03
Revalidate after material software, hardware, model, protocol, interface, or clinical-policy changes. Vendor statements are current product-family context; confirm the exact cleared release and installed options.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
This audit distinguishes completed source review from fields that have not yet been researched.
Human reviewedStatus
2026-09-04Last searched
26Fields reviewed
13Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads
The refreshed discovery snapshot contains no PubMed or ClinicalTrials.gov candidates; no external evidence was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. 4 FDA recall candidates were manually reviewed: 4 published and 0 rejected as a neighboring or otherwise inapplicable version. Native FDA recall identifiers produced 4 postmarket candidate records; 4 have been reviewed (4 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, fda decision material, vendor product page, peer reviewed literature, clinical trial registry, reimbursement policy, fda device recall, literature index, trial registry, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Public pricing: Not publicly available - checked 2026-09-03 - Exact FDA submission
No public list price for the exact cleared configuration was found. Obtain a written quote separating hardware or license basis, implementation, interfaces, infrastructure, training, service, upgrades, renewal, consumables, and exit costs.
Pricing model: Not yet reviewed
Setup and integration fees: Not yet reviewed
Recurring fees: Not yet reviewed
Minimum commitment: Not yet reviewed
Contract duration: Not yet reviewed
Renewal terms: Not yet reviewed
Cancellation terms: Not yet reviewed
Support and service terms: Not yet reviewed
Trial or pilot terms: Not yet reviewed
Data hosting location: Not yet reviewed
Data retention: Not yet reviewed
Documented data use: Not yet reviewed
Hardware requirements: Not yet reviewed
Network requirements: Not yet reviewed
Identity and access: Not yet reviewed
Security: Not verified - checked 2026-09-03 - Exact FDA submission
Public materials reviewed for this exact release do not establish the complete security posture. Request data-flow, identity, audit, encryption, retention, remote-access, vulnerability-management, backup, and incident-response evidence.
Authorized purpose: SurgicalAR displays CT and MR medical images and associated data as two-dimensional, multiplanar, three-dimensional, or volume-rendered views on a workstation, touchscreen, or head-mounted display to support surgical planning and intraoperative review; headset and mobile views are informational and non-diagnostic.
Modality
Radiological images; modality varies or is not specified in FDA list
AI-Rad Companion Engine is a Siemens cloud platform for multimodality, multivendor DICOM validation, storage, basic visualization, routing, and integration of optional post-processing extensions.
Modality
Radiological images; modality varies or is not specified in FDA list
Authorized purpose: Centricity Universal Viewer displays, communicates, stores, and processes supported medical images and related data for authorized users in clinical imaging workflows.
Modality
Radiological images; modality varies or is not specified in FDA list
Authorized purpose: AiORTA - Plan v2.0 is image-processing and analysis software for the labeled radiotherapy-planning workflow; exact modalities, structures, inputs, outputs, and user-review requirements remain submission-specific.
Modality
Radiological images; modality varies or is not specified in FDA list
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.